Celligenics
Enabling Cellular Therapeutics.
Singapore
7 employees
Series A
Total: $5.63M
Biotechnology
General Information
Singapore
BounceWatch is an independent company data service, not affiliated with Celligenics. To contact Celligenics, visit celligenics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Celligenics compare?
A PDF of Celligenics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Celligenics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Singapore Market
Biotechnology
About Celligenics
Business keywords: stem cell technology, regenerative medicine, healthcare solutions, personalized medicine, enterprise development, scientific research, investment finance, molecular biology, cell biology
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | SGD5.63M | 1 |
|
14 Jan 2019 |
Celligenics Alternatives & Competitors
View All Alternatives
Cell-specific culture matrices for improved cell functionality
Leading Animal Cell Therapy - Improving Animal Healthcare.
AMSBIO is a global supplier of research products and custom services for biological and pharmaceutic...
FAQ About Celligenics
Source: BounceWatch company record for Celligenics, https://bouncewatch.com/company/celligenics, updated 28 November 2024. When citing, please name BounceWatch and link this page.
